CSPC Zhongrun
 | A major contributor to this article appears to have a close connection with its subject. (December 2018) |
Hebei Zhongrun Pharmaceutical Co., Ltd (CSPC Zhongrun) (simplified Chinese: 石药集团河北中润制药有限公司; traditional Chinese: 石藥集團河北中潤制藥有限公司; pinyin: Shíyào jítuán héběi zhōngrùn zhìyào yǒuxiàn gōngsī) is one of China's largest producers of bulk antibiotic active pharmaceutical ingredients. CSPC Zhongrun produces both penicillin and cephalosporin series API.[1][2]
A joint venture established in 1989 by China Pharmaceutical Group Ltd (CHINA PHARMA, SEHK: 1093), CSPC Zhongrun employs more than 3,600 workers.
CSPC Zhongrun penicillin and cephalosporin Beta-lactam antibiotic products include 16 varieties of API and intermediates. The penicillin series includes penicillin G potassium crude, penicillin G potassium, penicillin G sodium, 6-APA, amoxicillin trihydrate, ampicillin trihydrate and ampicillin sodium.
The cephalosporin series includes intermediate 7-ACA, cefazolin sodium, cefazolin acid and ceftriaxone sodium. Meropenem API is also produced.
External links
[edit]- CSPC Zhongrun official website at the Wayback Machine (archived January 5, 2009)
- CSPC Pharmaceutical Group official website
References
[edit]- ↑ "CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD". CSPC Pharmaceutical Group Co., Ltd. Retrieved 2025-01-20.
- ↑ "CSPC Hebei Zhongrun Pharmaceutical Co Ltd - Company Profile and News". Bloomberg.com. Retrieved 2025-01-20.
